Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023

大麻の世界市場予測(~2023年)

◆タイトル:Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023
◆商品コード:FB-6762
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年11月27日
◆ページ数:150
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:食品・飲料
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

大麻の世界市場は、2018年の103億米ドルから2023年には394億米ドルに達し、30.7%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、大麻の医薬品用途の拡大や合法化の推進などが考えれられます。一方で、大麻使用にかかわる複雑な規制構造により、市場の成長は抑制される可能性があります。当調査レポートでは、大麻の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品タイプ(花、濃縮物)分析、化合物(THC優勢、CBD優勢、THC・CBDが均衡)分析、用途(医療、娯楽)分析、大麻の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Growing medicinal application of cannabis is expected to drive the overall growth of the cannabis market.”The cannabis market size is expected to grow from USD 10.3 billion in 2018 to USD 39.4 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period. The cannabis market is driven by various factors such as the growing medicinal application of cannabis and the increasing legalization of cannabis. However, a complex regulatory structure for the use of cannabis can hinder the growth of the market.
“The concentrates segment is expected to grow at the highest CAGR during the forecast period.”

The concentrates segment is the fastest-growing segment in the cannabis market, by product type. This is due to their ease in usage and their versatility in the method of delivery, such as dabbing, ingestible oils, and tinctures. Also, along with ingestion, concentrates can offer cleaner, smoother, and less-odiferous hits than flowers. Concentrates are being increasingly opted for over flowers, as these as more potent in nature. The potency of concentrates could also be modified as per requirement and usage, to evoke a higher consumer likeability.
“The THC-dominant segment, by compound, is projected to hold the largest market share during the forecast period.”
The THC-dominant segment is projected to hold the largest share and grow at the highest CAGR during the forecast period. The dominance of this segment is majorly attributed to the fact that THC is the psychoactive substance in cannabis products and is responsible for head high feeling. Even though high THC content is better known for its mind-altering euphoria, it has important medical benefits and is considered effective in relieving nausea, appetite loss, and insomnia.
“North America is projected to be the dominant market during the forecast period.”
The market in this region is primarily driven by the growth in the US and Canadian markets. The market in this region is driven by the increasing legalization of cannabis for both medical and recreational purposes all over North America and the increasing awareness among consumers regarding the health benefits of cannabis. The market is further fueled by the presence of major cannabis giants such as Canopy Growth Corporation, Aurora Cannabis Inc., and Medical Marijuana Inc., who are continuously investing and collaborating for the development of new products to fulfill the consumer demand.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the cannabis market.
By Company Type: Tier 1: 30%, Tier 2: 40%, and Tier 3: 30%
By Designation: C-level Executives: 75%, and Managers: 25%
By Region: North America: 50%, South America: 20%, Europe: 20%, RoW: 10%

The cannabis market comprises major providers such as Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Tikun Olam (Israel), Cannabis Science Inc. (US), Aphria Inc. (Canada), and Maricann Group Inc. (Canada) among others. The study includes an in-depth competitive analysis of these key players in the cannabis market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the cannabis market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product type, application, compound, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall cannabis market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to position their businesses better, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and will provide them with information on the key market drivers, restraints, challenges, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SEGMENTATION 16
1.4 REGIONS COVERED 16
1.5 PERIODIZATION CONSIDERED 17
1.6 CURRENCY CONSIDERED 17
1.7 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key data from primary sources 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 BOTTOM-UP APPROACH 22
2.3 DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25
2.5 LIMITATIONS OF THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 32
4.1 ATTRACTIVE OPPORTUNITIES IN THE CANNABIS MARKET 32
4.2 CANNABIS MARKET: MAJOR COUNTRIES 33
4.3 CANNABIS MARKET IN NORTH AMERICA, BY PRODUCT TYPE & COUNTRY 34
4.4 CANNABIS MARKET, BY APPLICATION & REGION 35
4.5 CANNABIS MARKET, BY COMPOUND & REGION 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Growing medicinal application of cannabis 37
5.2.1.2 Increasing legalization of cannabis 37
5.2.2 RESTRAINTS 38
5.2.2.1 Complex regulatory structure for the usage of cannabis 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Product development via research and novel product delivery solutions 38
5.2.4 CHALLENGES 39
5.2.4.1 Declining prices as product gets commoditized 39
5.3 VALUE CHAIN: CANNABIS MARKET 39
5.4 GLOBAL REGULATORY OVERVIEW 40
5.5 REGULATORY OVERVIEW, BY COUNTRY 42
5.5.1 US 42
5.5.1.1 Nevada 42
5.5.1.2 Colorado 42
5.5.1.3 Maine 43
5.5.1.4 California 43
5.5.1.5 Massachusetts 43
5.5.1.6 Alaska 43
5.5.1.7 Oregon 43
5.5.1.8 Washington 43
5.5.1.9 Washington DC 44
5.5.1.10 Vermont 44
5.5.2 CANADA 44
5.5.3 GERMANY 44
5.5.4 ITALY 44
5.5.5 DENMARK 44
5.5.6 CZECH REPUBLIC 45
5.5.7 CHILE 45
5.5.8 NETHERLANDS 45
5.5.9 COLOMBIA 45
5.5.10 URUGUAY 45
5.5.11 AUSTRALIA 45
5.5.12 ISRAEL 45
6 CANNABIS MARKET, BY PRODUCT TYPE 46
6.1 INTRODUCTION 47
6.2 FLOWER 48
6.2.1 INCREASING USAGE OF CANNABIS FOR RECREATIONAL PURPOSES IS EXPECTED TO FUEL THE MARKET GROWTH FOR THESE PRODUCTS 48
6.3 CONCENTRATES 49
6.3.1 A WIDE VARIETY OF DELIVERY METHODS HAVE MADE THE MARKET FOR CANNABIS CONCENTRATES EXTREMELY FAVORABLE AMONGST CONSUMERS 49
6.4 OTHERS 50
6.4.1 LARGE NUMBER OF FOOD & BEVERAGE MANUFACTURING COMPANIES VENTURING INTO THE CANNABIS-INFUSED EDIBLES CATEGORY EXPECTED TO DRIVE THE MARKET GROWTH 50
7 CANNABIS MARKET, BY APPLICATION 51
7.1 INTRODUCTION 52
7.2 MEDICAL 53
7.2.1 INCREASING USAGE OF CANNABIS FOR PAIN, NEUROLOGICAL HEALTH,
AND MENTAL HEALTH MANAGEMENT IS DRIVING THE MARKET FOR MEDICAL CANNABIS 53
7.2.1.1 Pain management 53
7.2.1.2 Neurological health management 53
7.2.1.3 Mental health management 53
7.2.1.4 Others 53
7.3 RECREATIONAL 54
7.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO SIGNIFICANTLY BOOST MARKET GROWTH 54
8 CANNABIS MARKET, BY COMPOUND 55
8.1 INTRODUCTION 56
8.2 TETRAHYDROCANNABINOL (THC)-DOMINANT 57
8.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS COULD HELP PROPEL THE MARKET FOR THC-DOMINANT CANNABIS STRAINS 57
8.3 CANNABIDIOL (CBD)-DOMINANT 58
8.3.1 USAGE OF CANNABIDIOL FOR MEDICINAL APPLICATIONS IS DRIVING
THE MARKET FOR CBD-DOMINANT CANNABIS PRODUCTS 58
8.4 BALANCED THC & CBD 59
8.4.1 BALANCED THC & CBD STRAINS PRODUCING EFFECTS, WHICH HELP DIMINISH THE PSYCHOACTIVE PROPERTIES OF THC, ARE EXPECTED TO DRIVE THE MARKET GROWTH 59
9 CANNABIS MARKET, BY REGION 60
9.1 INTRODUCTION 61
9.2 NORTH AMERICA 63
9.2.1 US 65
9.2.1.1 Growing legalization of both medical and recreational cannabis in several states to drive the market in the US 65
9.2.2 CANADA 66
9.2.2.1 Legalization of recreational cannabis to drive the market in Canada 66
9.2.3 MEXICO 68
9.2.3.1 Legalization of medical cannabis to drive the Mexican market 68
9.3 SOUTH AMERICA 70
9.3.1 CHILE 71
9.3.1.1 Increasing awareness among consumers about the benefits of medical cannabis in the treatment of chronic pain, seizures,
and nausea is driving the market in Chile 71
9.3.2 COLOMBIA 73
9.3.2.1 A high percentage of population suffering from chronic diseases is driving the Colombian cannabis market 73
9.3.3 URUGUAY 74
9.3.3.1 The fully legalized cannabis industry with eased regulations is driving the market in Uruguay 74
9.3.4 REST OF SOUTH AMERICA 75
9.3.4.1 Legalization of medical cannabis is the major driver for the market in the rest of South America 75
9.4 EUROPE 77
9.4.1 GERMANY 79
9.4.1.1 Complete health insurance coverage for the use of medical cannabis is driving the German market 79
9.4.2 ITALY 80
9.4.2.1 Increase in demand for cannabis coupled with the issuance of import licenses to drive growth in the Italian cannabis market 80
9.4.3 FRANCE 82
9.4.3.1 The healthcare system in France is driving the market growth 82
9.4.4 THE NETHERLANDS 83
9.4.4.1 Strong supporting infrastructure of pharmacies is driving the market in the Netherlands 83
9.4.5 REST OF EUROPE 85
9.4.5.1 Legalization of medical cannabis is the major driver for the market in the rest of Europe 85
9.5 REST OF THE WORLD (ROW) 86
9.5.1 ISRAEL 88
9.5.1.1 Agricultural & technical innovations coupled with liberal government policies to drive the market in Israel 88
9.5.2 AUSTRALIA 89
9.5.2.1 Improved access to medical cannabis is projected to drive the market in Australia 89
10 COMPETITIVE LANDSCAPE 91
10.1 OVERVIEW 91
10.2 KEY MARKET STRATEGIES 93
10.3 RANKING OF KEY PLAYERS, 2018 94
10.4 INVESTMENT OVERVIEW 94
10.5 COMPETITIVE SCENARIO 95
10.5.1 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS 95
10.5.2 NEW PRODUCT LAUNCHES 96
10.5.3 EXPANSIONS & INVESTMENTS 96
10.5.4 ACQUISITIONS 97

11 COMPANY PROFILES 98
(Business overview, Products offered, Recent developments, SWOT analysis & MnM View)*
11.1 CANOPY GROWTH CORPORATION 98
11.2 AURORA CANNABIS INC. 104
11.3 MEDMEN 108
11.4 TERRA TECH CORP. 111
11.5 APHRIA INC. 114
11.6 VIVO CANNABIS INC. 117
11.7 CHRONOS GROUP INC. 120
11.8 MEDICAL MARIJUANA, INC. 125
11.9 STENOCARE 129
11.10 TIKUN OLAM 130
11.11 ORGANIGRAMS HOLDING INC. 132
11.12 CANNABIS SCIENCE INC. 135
11.13 MARICANN GROUP INC. 137
11.14 TILRAY INC 139
11.15 HEXO 141
*Details on Business overview, Products offered, Recent developments, SWOT analysis & MnM View might not be captured in case of unlisted companies.
12 APPENDIX 143
12.1 DISCUSSION GUIDE 143
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 146
12.3 AVAILABLE CUSTOMIZATIONS 148
12.4 RELATED REPORTS 148
12.5 AUTHOR DETAILS 149

LIST OF TABLES

TABLE 1 US DOLLAR EXCHANGE RATES CONSIDERED, 2015–2018 17
TABLE 2 CANNABIS MARKET SNAPSHOT, 2018 VS. 2023 27
TABLE 3 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 47
TABLE 4 FLOWER MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 48
TABLE 5 CONCENTRATES MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 49
TABLE 6 OTHERS MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 50
TABLE 7 CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 52
TABLE 8 MEDICAL CANNABIS MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 54
TABLE 9 RECREATIONAL CANNABIS MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 54
TABLE 10 CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 56
TABLE 11 THC-DOMINANT CANNABIS MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 12 CBD-DOMINANT CANNABIS MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 58
TABLE 13 BALANCED THC & CBD CANNABIS MARKET SIZE, BY REGION,
2016–2023 (USD MILLION) 59
TABLE 14 CANNABIS MARKET SIZE, BY REGION, 2016–2023 (USD MILLION) 62
TABLE 15 NORTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY,
2016–2023 (USD MILLION) 64
TABLE 16 NORTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 64
TABLE 17 NORTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 64
TABLE 18 NORTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2023 (USD MILLION) 65
TABLE 19 US: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 65
TABLE 20 US: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 66
TABLE 21 US: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 66
TABLE 22 CANADA: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 67
TABLE 23 CANADA: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 67
TABLE 24 CANADA: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 67
TABLE 25 MEXICO: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 68
TABLE 26 MEXICO: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 69
TABLE 27 MEXICO: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 69
TABLE 28 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COUNTRY,
2016–2023 (USD MILLION) 70
TABLE 29 SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 70
TABLE 30 SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 71
TABLE 31 SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2023 (USD MILLION) 71
TABLE 32 CHILE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 72
TABLE 33 CHILE: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 72

TABLE 34 CHILE: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 72
TABLE 35 COLOMBIA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 73
TABLE 36 COLOMBIA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 73
TABLE 37 COLOMBIA: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 74
TABLE 38 URUGUAY: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 74
TABLE 39 URUGUAY: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 75
TABLE 40 URUGUAY: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 75
TABLE 41 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 76
TABLE 42 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 76
TABLE 43 REST OF SOUTH AMERICA: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2023 (USD MILLION) 76
TABLE 44 EUROPE: CANNABIS MARKET SIZE, BY COUNTRY, 2016–2023 (USD MILLION) 78
TABLE 45 EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 78
TABLE 46 EUROPE: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 78
TABLE 47 EUROPE: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 79
TABLE 48 GERMANY: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 79
TABLE 49 GERMANY: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 80
TABLE 50 GERMANY: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 80
TABLE 51 ITALY: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 81
TABLE 52 ITALY: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 81
TABLE 53 ITALY: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 81
TABLE 54 FRANCE: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 82
TABLE 55 FRANCE: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 82
TABLE 56 FRANCE: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 83
TABLE 57 THE NETHERLANDS: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 83
TABLE 58 THE NETHERLANDS: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 84
TABLE 59 THE NETHERLANDS: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2023 (USD MILLION) 84
TABLE 60 REST OF EUROPE: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 85
TABLE 61 REST OF EUROPE: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 85
TABLE 62 REST OF EUROPE: CANNABIS MARKET SIZE, BY COMPOUND,
2016–2023 (USD MILLION) 86
TABLE 63 ROW: CANNABIS MARKET SIZE, BY COUNTRY, 2016-2023 (USD MILLION) 86
TABLE 64 ROW: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016-2023 (USD MILLION) 87
TABLE 65 ROW: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 87
TABLE 66 ROW: CANNABIS MARKET SIZE, BY COMPOUND, 2016-2023 (USD MILLION) 87
TABLE 67 ISRAEL: CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2016–2023 (USD MILLION) 88

TABLE 68 ISRAEL: CANNABIS MARKET SIZE, BY APPLICATION, 2016–2023 (USD MILLION) 89
TABLE 69 ISRAEL: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 89
TABLE 70 AUSTRALIA: CANNABIS MARKET SIZE, BY PRODUCT TYPE,
2016–2023 (USD MILLION) 90
TABLE 71 AUSTRALIA: CANNABIS MARKET SIZE, BY APPLICATION,
2016–2023 (USD MILLION) 90
TABLE 72 AUSTRALIA: CANNABIS MARKET SIZE, BY COMPOUND, 2016–2023 (USD MILLION) 90
TABLE 73 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS,
2013–2018 95
TABLE 74 NEW PRODUCT LAUNCHES, 2013–2018 96
TABLE 75 EXPANSIONS & INVESTMENTS, 2013–2018 96
TABLE 76 ACQUISITIONS, 2013–2018 97


LIST OF FIGURES

FIGURE 1 CANNABIS MARKET: RESEARCH DESIGN 19
FIGURE 2 CANNABIS MARKET: BOTTOM-UP APPROACH 22
FIGURE 3 CANNABIS MARKET: TOP-DOWN APPROACH 23
FIGURE 4 DATA TRIANGULATION METHODOLOGY 24
FIGURE 5 CANNABIS MARKET SIZE, BY PRODUCT TYPE, 2018 VS. 2023 (USD MILLION) 28
FIGURE 6 CANNABIS MARKET SIZE, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 29
FIGURE 7 CANNABIS MARKET SIZE, BY COMPOUND, 2018 VS. 2023 (USD MILLION) 30
FIGURE 8 CANNABIS MARKET SHARE (VALUE), BY REGION, 2017 31
FIGURE 9 GROWING MEDICINAL APPLICATION OF CANNABIS AND INCREASING LEGALIZATION OF CANNABIS TO DRIVE THE DEMAND FOR CANNABIS 32
FIGURE 10 GERMANY TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 11 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET FOR CANNABIS IN TERMS OF COUNTRY WHILE THE FLOWER SEGMENT DOMINATED IN TERMS OF PRODUCT TYPE IN 2017 34
FIGURE 12 NORTH AMERICA DOMINATED THE CANNABIS MARKET ACROSS BOTH APPLICATIONS THROUGH 2023 35
FIGURE 13 THC DOMINANT SEGMENT TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 35
FIGURE 14 CANNABIS MARKET DYNAMICS 36
FIGURE 15 VALUE CHAIN: CANNABIS MARKET 40
FIGURE 16 GLOBAL CANNABIS REGULATORY OVERVIEW INDICATING LEGALITY OF MEDICAL AND RECREATIONAL CANNABIS 40
FIGURE 17 NEW REVENUE POCKETS FOR THE CANNABIS MARKET 41
FIGURE 18 US CANNABIS REGULATORY OVERVIEW 42
FIGURE 19 CANNABIS MARKET SHARE, BY PRODUCT TYPE, 2018 VS. 2023 47
FIGURE 20 CANNABIS MARKET SHARE, BY APPLICATION, 2018 VS. 2023 52
FIGURE 21 CANNABIS MARKET SHARE, BY COMPOUND, 2018 VS. 2023 56
FIGURE 22 US ACCOUNTED FOR THE LARGEST SHARE OF THE CANNABIS MARKET IN 2017 61
FIGURE 23 NORTH AMERICA: CANNABIS MARKET SNAPSHOT 63
FIGURE 24 EUROPE: CANNABIS MARKET SNAPSHOT 77
FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE CANNABIS MARKET,
2013-2018 92
FIGURE 26 NUMBER OF DEVELOPMENTS BETWEEN 2018 AND 2016 93
FIGURE 27 CANOPY GROWTH CORPORATION, LED THE CANNABIS MARKET IN 2018 94
FIGURE 28 INVESTMENT OVERVIEW 94
FIGURE 29 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT 98
FIGURE 30 CANOPY GROWTH CORPORATION: SWOT ANALYSIS 103
FIGURE 31 AURORA CANNABIS INC.: COMPANY SNAPSHOT 104
FIGURE 32 AURORA CANNABIS INC.: SWOT ANALYSIS 107
FIGURE 33 MEDMEN: COMPANY SNAPSHOT 108
FIGURE 34 MEDMEN: SWOT ANALYSIS 110

FIGURE 35 TERRA TECH CORP.: COMPANY SNAPSHOT 111
FIGURE 36 TERRA TECH CORP.: SWOT ANALYSIS 113
FIGURE 37 APHRIA INC.: COMPANY SNAPSHOT 114
FIGURE 38 APHRIA INC.: SWOT ANALYSIS 116
FIGURE 39 VIVO CANNABIS INC.: COMPANY SNAPSHOT 117
FIGURE 40 CHRONOS GROUP INC.: COMPANY SNAPSHOT 120
FIGURE 41 MEDICAL MARIJUANA INC.: COMPANY SNAPSHOT 125
FIGURE 42 ORGANIGRAMS HOLDING INC.: COMPANY SNAPSHOT 132
FIGURE 43 MARICANN GROUP INC. GROWTH: COMPANY SNAPSHOT 137
FIGURE 44 HEXO: COMPANY SNAPSHOT 141


★調査レポート[大麻の世界市場予測(~2023年)] ( Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023 / FB-6762) 販売に関する免責事項
[大麻の世界市場予測(~2023年)] ( Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023 / FB-6762) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆